Germany · Delayed Price · Currency is EUR SCHOTT Pharma AG & Co. KGaA Company Description
SCHOTT Pharma AG & Co. KGaA develops, manufactures, and sells drug containment solutions and delivery systems for injectable drugs for pharma, biotech, and life science industries worldwide.
It offers syriQ, a glass syringe for vaccines; syriQ BioPure, a glass syringe for biologics; syriQ BioPure silicone-free, a prefillable and silicone-free glass syringe for biologics; SCHOTT TOPPAC, a polymer syringe; SCHOTT TOPPAC cosmetic, a polymer syringe for aesthetic treatments; SCHOTT TOPPAC freeze, a polymer syringe for deep-cold applications; SCHOTT TOPPAC sensitive, a polymer syringe for sensitive drugs; SCHOTT TOPPAC infuse, a polymer syringe for infusion therapy; SCHOTT TOPPAC unique, a polymer container; and SCHOTT TOPPAC cartridge.
The company also provides pharmaceutical glass cartridge, such as cartriQ for peptide and protein-based injectables; cartriQ Large Volume for large-volume injectables; Cartridges Double Chamber for lyophilized drugs; Cartridges Break Resistant; and TopLine and StandardLine cartridges and vials.
In addition, the company offers pharmaceutical glass vial, including adaptiQ for injectables; EVERIC pure for unmatched drug stability; EVERIC freeze for deep-cold applications; EVERIC care for a pH range; EVERIC strong & smooth for the filling line performance; EVERIC smart; EVERIC plus for sensitive drug formulations; and EVERIC Iyo to avoid fogging for lyophilized drugs.
Further, it provides pharmaceutical glass ampoule products comprise Ampoules easyOPC for ampoule opening; Ampoules Anti-Counterfeiting for protection against drug counterfeiting; and StandardLine ampoules.
It also provides containment and drug delivery, analytics, fill-and-finish, regulatory, and sustainability services.
The company was founded in 1884 and is headquartered in Mainz, Germany. SCHOTT Pharma AG & Co. KGaA operates as a subsidiary of Schott Glaswerke Beteiligungs- Und Export Gmbh.
| Country | Germany |
| Founded | 1884 |
| Industry | Medical Instruments & Supplies |
| Sector | Healthcare |
| Employees | 4,690 |
| CEO | Andreas Reisse |
Contact Details
Address: Hattenbergstrasse 10 Mainz, 55122 Germany | |
| Phone | 49 6131 66 0 |
| Website | schott-pharma.com |
Stock Details
| Ticker Symbol | 1SXP |
| Exchange | Deutsche Börse Xetra |
| Fiscal Year | October - September |
| Reporting Currency | EUR |
| ISIN Number | DE000A3ENQ51 |
| SIC Code | 3221 |
Key Executives
| Name | Position |
|---|---|
| Andreas Reisse | Chairperson of Management Board and Chief Executive Officer of SCHOTT Pharma Management AG |
| Reinhard Josef Mayer | Chief Financial Officer |
| Tobias Erfurth | Head of Investor Relations |